Search

Author/Creator Robins, Deborah A.

1. A Randomized, Double‐Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density. (February 2015)

Authors:
Recker, Robert R.; Benson, Charles T.; Matsumoto, Toshio; Bolognese, Michael A.; Robins, Deborah A.; Alam, Jahangir; Chiang, Alan Y; Hu, Leijun; Krege, John H; Sowa, Hideaki; Mitlak, Bruce H.; Myers, Stephen L.
Journal:
Journal of bone and mineral research
Issue:
Volume 30:Number 2(2015:Feb.)
Page Start:
216
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and tolerability of tirzepatide, a dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist in patients with type 2 diabetes: A 12‐week, randomized, double‐blind, placebo‐controlled study to evaluate different dose‐escalation regimens. Issue 6 (11th February 2020)

Authors:
Frias, Juan Pablo; Nauck, Michael A.; Van, Joanna; Benson, Charles; Bray, Ross; Cui, Xuewei; Milicevic, Zvonko; Urva, Shweta; Haupt, Axel; Robins, Deborah A.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 22:Issue 6(2020)
Page Start:
938
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabetes: A post hoc analysis. Issue 1 (11th October 2021)

Authors:
Wilson, Jonathan M.; Lin, Yanzhu; Luo, M. Jane; Considine, Gary; Cox, Amy L.; Bowsman, Lenden M.; Robins, Deborah A.; Haupt, Axel; Duffin, Kevin L.; Ruotolo, Giacomo
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 24:Issue 1(2022)
Page Start:
148
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗